X
Xin-Yi Xia
Researcher at Nanjing University
Publications - 105
Citations - 1132
Xin-Yi Xia is an academic researcher from Nanjing University. The author has contributed to research in topics: Male infertility & Sperm. The author has an hindex of 16, co-authored 104 publications receiving 918 citations.
Papers
More filters
Journal ArticleDOI
METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.
Xiaoxiang Chen,Mu Xu,Xueni Xu,Xueni Xu,Kaixuan Zeng,Kaixuan Zeng,Xiangxiang Liu,Li Sun,Bei Pan,Bangshun He,Yuqin Pan,Huiling Sun,Xin-Yi Xia,Shukui Wang +13 more
TL;DR: It is found that METTL14 was downregulated in CRC tissues and cell lines, and closely correlated with overall survival (OS) and novel insight into m6A modification in CRC progression is provided.
Journal ArticleDOI
Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test.
TL;DR: Results suggested that antidepressant properties of the ethanolic extract of Curcuma longa was mediated through regulations of neurochemical and neuroendocrine systems and it may be a useful agent against depression.
Journal ArticleDOI
Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice.
TL;DR: The results suggest that TFPC may possess potent and rapid antidepressant properties that are mediated via MAO, the HPA axis and oxidative systems and these antidepressant actions could make TFPC a potentially valuable drug for the treatment of depression in the elderly.
Journal ArticleDOI
Exposure of Juvenile Rats to the Phytoestrogen Daidzein Impairs Erectile Function in a Dose‐Related Manner in Adulthood
TL;DR: Exposure of juvenile rats to daidzein in a relatively large amount could adversely affect penile erection in adulthood, according to results suggested.
Journal ArticleDOI
Effects of ginsenoside Rg1 on glucose metabolism and liver injury in streptozotocin-induced type 2 diabetic rats.
TL;DR: The hepatoprotective effects of ginsenoside Rg1 in the T2-DM rat model suggests its clinical potential as an adjuvant drug for T1-DM therapy, especially for T 2-DM patients with fatty liver disease.